More recent studies have discovered that these principal groups can be further stratified within groups, with an important distinction made for SHH group tumours based on TP53 status as TP53-mutant patients exhibit significantly poorer prognosis compared to TP53-wild-type patients [45, 46]. Here, TP53 is linked to neoplasm.